Preparing for Immunotherapy Before Colorectal Cancer Surgery: A Step-by-Step Guide

Introduction

Imagine a treatment that could keep you cancer-free for nearly three years after just nine weeks of therapy before surgery. That's the promising outcome of a UK-led trial where patients with a specific type of colorectal cancer received a short burst of the immunotherapy drug pembrolizumab prior to surgery. This approach challenges the traditional path of surgery followed by months of chemotherapy. If you or a loved one are considering this groundbreaking option, understanding the steps involved can help you navigate the journey with confidence. This guide breaks down the process from screening to post-surgery follow-up, based on the latest clinical findings.

What You Need

• Medical confirmation of mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) colorectal cancer – the type that responds best to pembrolizumab.
• A healthcare team that includes an oncologist, surgeon, and nurse coordinator experienced in immunotherapy.
• Access to pembrolizumab (Keytruda) – typically administered via intravenous infusion at a hospital or clinic.
• Pre-surgery imaging (CT scans, MRI, or PET) to map the tumor and assess staging.
• Blood tests to check organ function and immune status before starting immunotherapy.
• Support network – family, friends, or a patient advocate to help during treatment and recovery.
• Transportation to and from treatment appointments, as infusions take about 30 minutes plus observation time.

Step-by-Step Guide

Step 1: Confirm Your Cancer Subtype

Your doctor will test your tumor tissue for mismatch repair deficiency (dMMR) or high microsatellite instability (MSI-H). These biological markers indicate that your cancer may be highly responsive to immune checkpoint inhibitors like pembrolizumab. Without this specific subtype, the approach may not be as effective. Ensure you obtain a clear pathology report confirming dMMR/MSI-H status.

Step 2: Discuss the Treatment Plan with Your Oncologist

Meet with your oncologist to review the trial evidence. Explain that in the recent study, patients received pembrolizumab every three weeks for nine weeks (a total of three doses) before surgery. Ask about potential side effects, which can include fatigue, rash, or immune-related reactions. Your oncologist will help you decide if this short-course immunotherapy is appropriate for your stage and overall health.

Step 3: Undergo Baseline Testing

Before your first infusion, complete all required tests: a complete blood count, liver and kidney function panels, thyroid function tests, and a chest X-ray or CT scan. These establish a baseline to monitor how your body responds to the drug. You may also need a colonoscopy with biopsies to document the tumor’s size and location.

Step 4: Start the Nine-Week Immunotherapy Course

Schedule your first pembrolizumab infusion. Each session lasts about 30 to 60 minutes, followed by a short observation period. You’ll receive infusions on Day 1, Day 22, and Day 43 (or every three weeks). During the course, report any new symptoms such as fever, coughing, or skin changes to your care team immediately. Keep a symptom diary to share during follow-up visits.

Step 5: Monitor Your Response

After the second or third infusion, your doctor may order a mid-treatment CT scan to assess tumor shrinkage. In the successful trial, many patients showed significant reduction in tumor size after just nine weeks. If your tumor responds well, you may proceed to surgery with a better chance of complete removal and less invasive procedures.

Step 6: Plan the Surgery

Once the immunotherapy course is complete, schedule your surgery within two to four weeks. The type of surgery depends on tumor location and size – it could be a polypectomy, segmental colectomy, or more extensive resection. Your surgeon will coordinate with the oncology team to remove the tumor and surrounding lymph nodes. Discuss whether you need a colostomy bag or if you can have a primary anastomosis.

Step 7: Undergo Surgery and Begin Recovery

On the day of surgery, you’ll receive general anesthesia. The operation typically takes two to four hours. Afterward, you’ll stay in the hospital for monitoring – usually three to seven days. Pain management, walking early, and slowly advancing your diet are key to recovery. Follow your surgeon’s instructions regarding wound care, activity restrictions, and when to call for help.

Step 8: Post-Surgery Evaluation and Follow-Up

Once the pathology report from your surgery is ready, your oncologist will check if the cancer has been completely removed with clear margins. In the trial, nearly all patients had no detectable cancer at that point. However, because the immunotherapy was given before surgery, you may not need additional chemotherapy. Still, you will need regular follow-ups every three to six months with blood tests (CEA marker) and CT scans to watch for recurrence.

Tips for Success

• Stay organized: Keep a folder with all test results, infusion dates, and contact numbers for your care team.
• Manage side effects proactively: Mild fatigue is common; rest when needed. For skin rashes, use moisturizers and consult a dermatologist if severe. Report any shortness of breath or jaundice immediately.
• Nutrition matters: Eat a balanced diet rich in protein and fiber to support your immune system before and after surgery. Consult a dietitian if you have trouble eating.
• Emotional support: Join a colorectal cancer support group or talk to a counselor. The psychological burden of cancer treatment can be eased by sharing experiences.
• Consider clinical trials: If you are not a candidate for this specific trial, ask your doctor about other immunotherapy trials for colorectal cancer. The field is evolving rapidly.
• Insurance and costs: Check with your insurance provider about coverage for pembrolizumab before surgery, as it may be considered off-label in some settings. Patient assistance programs may help with costs.

This new approach – immunotherapy before surgery – offers a shorter, less toxic path to long-term remission. By following these steps and working closely with your medical team, you can maximize the chances of a successful outcome. Always remember that each person’s journey is unique; your doctor will tailor the plan to your specific needs.